In prostate cancer 22Rv1 and breast cancer MCF7-10A cells, EPHB4 suppressed cancer cell growth via EPHB4/EFB2 signalling pathway in the presence of EFNB2; however, EPHB4 promoted cancer cell growth in the absence of EFNB2 [46]. This evidence concerns the gene EFNB2 and breast carcinoma.